Published May 2001 | Version v1
Journal article

Comparison of in vivo dopamine D2 receptor binding of [123I]AIBZM and [123I]IBZM in rat brain

Description

[123I]AIBZM, (S)-5-[123I]-Iodo-N-[(1-ethyl-2-pyrrolidinyl)] methyl-4-amine-2-methoxybenzamide is a derivative with high affinity for the D2 receptor. Labeling was achieved by the IodogenTM method. The in vivo affinity for the D2 receptor and the biological characteristics were performed in rats. The brain uptake of [123I]AIBZM was significantly lower, however the striatum/cerebellum ratio (2h p.i.) was higher than that of [123I]IBZM. Because of the high affinity and its possibly lower unspecific binding compared to [123I]IBZM, [123I]AIBZM may be a potential imaging agent for the D2 dopamine receptor

Additional details

Identifiers

PII
S0969805101001998;

Publishing Information

Journal Title
Nuclear Medicine and Biology
Journal Volume
28
Journal Issue
4
Journal Page Range
p. 383-389
ISSN
0969-8051
CODEN
NMBIEO

Optional Information

Copyright
Copyright (c) 2001 Elsevier Science B.V., Amsterdam, The Netherlands, All rights reserved.